During this recent webinar Dr. Cheryl Wellington discussed the explosion of research on blood biomarkers for a variety of neurological indications. Listen in as she talks about hypoxic ischemic brain injury that occurs after cardiac arrest and the use of biomarkers like NfL, GFAP, total TAU and others to measure brain health.
About the Speaker:
Dr. Cheryl Wellington, Professor
Department of Pathology and Laboratory Medicine
University of British Columbia
Dr. Cheryl Wellington is a professor at the University of British Columbia whose research is highly multidisciplinary with major efforts in Alzheimer’s Disease and Traumatic Brain Injury. Her laboratory is the leading Canadian site for research on blood biomarkers using the Quanterix single molecule array (Simoa) platform.